Zielinski M. Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer. World J Respirol 2015; 5(2): 166-175 [DOI: 10.5320/wjr.v5.i2.166]
Corresponding Author of This Article
Marcin Zielinski, MD, PhD, Department of Thoracic Surgery, Pulmonary Hospital, Ul. Gładkie 1, 34500 Zakopane, Poland. marcinz@mp.pl
Research Domain of This Article
Surgery
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Zielinski M. Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer. World J Respirol 2015; 5(2): 166-175 [DOI: 10.5320/wjr.v5.i2.166]
World J Respirol. Jul 28, 2015; 5(2): 166-175 Published online Jul 28, 2015. doi: 10.5320/wjr.v5.i2.166
Current methods of staging and restaging of the mediastinal nodes in non-small-cell lung cancer
Marcin Zielinski
Marcin Zielinski, Department of Thoracic Surgery, Pulmonary Hospital, 34500 Zakopane, Poland
Author contributions: Zielinski M designed, performed research, analyzed data and wroted the paper.
Conflict-of-interest statement: The author declares no conflicts of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Marcin Zielinski, MD, PhD, Department of Thoracic Surgery, Pulmonary Hospital, Ul. Gładkie 1, 34500 Zakopane, Poland. marcinz@mp.pl
Telephone: +48-18-2015045 Fax: +48-18-2014632
Received: November 24, 2014 Peer-review started: November 26, 2014 First decision: January 20, 2015 Revised: April 13, 2015 Accepted: July 7, 2015 Article in press: July 8, 2015 Published online: July 28, 2015 Processing time: 252 Days and 17.1 Hours
Core Tip
Core tip: All methods currently used for staging of non-small-cell lung cancer are analyzed. These methods include imaging techniques [computer tomography (CT), positron emission tomography (PET) combined with CT (PET/CT)], endoscopic/ultrasound techniques endobronchial ultrasound/transbronchial needle aspiration and endoscopic ultrasound/fine needle aspiration and surgical techniques standard cervical mediastinoscopy, video-assisted mediastinoscopy, extended mediastinoscopy, video-assisted mediastinoscopic lymphadenectomy, transcervical extended mediastinal lymphadenectomy, anterior mediastinotomy (chamberlain procedure) and video-assisted thoracic surgery. The issue of intraoperative staging is also described. Finally, the author’s proposed algorithm of staging, both for primary staging and restaging after neoadjuvant therapy is presented.
